ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
CIDEC Restricts Liver Regeneration by Disturbing Lipid Droplet Triglyceride Turnover.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- CIDEC Restricts Liver Regeneration by Disturbing Lipid Droplet Triglyceride Turnover.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
The transient accumulation of triglyceride (TG)-enriched lipid droplets (LDs) in hepatocytes during early liver regeneration is critical for generation but remains mechanistically unclear, particularly the roles of LD fusion-associated proteins in lipid mobilization. Here, through integrated lipidomic and transcriptomic analyses, Cell death-inducing DNA fragmentation factor-like Effector C (CIDEC), an LD-associated protein upregulated during this phase is identified, as a negative regulator of regeneration through its unexpected role in sequestering TG within LDs. Mechanistically, CIDEC acts as a metabolic gatekeeper: its depletion after peak LD accumulation promotes TG mobilization and enhances fatty acid oxidation (FAO)-driven regeneration. This pro-regenerative effect is abolished by FAO inhibition, underscoring the central role of TG catabolism. Conversely, overexpression of CIDEC or the TG biosynthetic enzyme Diacylglycerol O-acyltransferase 2 (DGAT2) exacerbates TG retention and impairs liver regeneration. Notably, CIDEC depletion significantly improves regenerative outcomes in mice with chronic steatosis. These findings reveal a previously unrecognized role for LD fusion in regulating the TG storage-utilization balance, where its suppression promotes metabolic flexibility to meet the energetic demands of liver regeneration. This metabolic checkpoint may be targeted to overcome impaired liver regeneration associated with fatty liver disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.